About the Company
Medpace Holdings, Inc. (alt. Medpace) is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio. The company started trading stock as a public firm in 2016.
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological Research
Employees
5385
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MEDP News
Medpace Holdings, Inc. Reports First Quarter 2024 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, ...
Medpace Holdings Inc MEDP
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to Medpace First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and ...
Medpace Holdings, Inc. Reports First Quarter 2024 Results
EBITDA is calculated as net income attributable to Medpace Holdings, Inc. before income tax expense, interest expense, net, depreciation and amortization. EBITDA margin is calculated by dividing ...
Medpace Holdings, Inc. Reports First Quarter 2024 Results
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Medpace GAAP EPS of $3.20 beats by $0.73, revenue of $511M misses by $1M
Q1 GAAP EPS of $3.20 beats by $0.73. Revenue of $511M (+17.7% Y/Y) misses by $1M. 2024 Financial Guidance The Company ...
OBK Stock Earnings: Origin Bancorp Beats EPS, Beats Revenue for Q1 2024
Stock Market News, Stock Advice & Trading Tips Origin Bancorp (NYSE:OBK) just reported results for the first quarter of ...
Loading the latest forecasts...